Condition: Moderate to Severe Plaque Psoriasis · Psoriatic Arthritis · Axial Spondyloarthritis · Sponsor: UCB Biopharma SRL
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
This description comes directly from the study's public registry record.
UCB Cares · 1-844-599-2273 (USA) · ucbcares@ucb.com
UCB Cares · 001 844 599 2273 (USA) · ucbcares@ucb.com
Always discuss trial participation with your own doctor first.
| Up0122 105 | Santa Monica, California, United States | Recruiting |
| Up0122 103 | South Miami, Florida, United States | Recruiting |
| Up0122 104 | Boston, Massachusetts, United States | Recruiting |
| Up0122 106 | Chapel Hill, North Carolina, United States | Recruiting |
| Up0122 102 | Durham, North Carolina, United States | Recruiting |
| Up0122 101 | Milwaukee, Wisconsin, United States | Recruiting |
| Up0122 202 | Calgary, Canada | Recruiting |
| Up0122 201 | Vancouver, Canada | Recruiting |
| Up0122 301 | Freiburg im Breisgau, Germany | Recruiting |
| Up0122 303 | Herne, Germany | Recruiting |
| Up0122 501 | Barcelona, Spain | Recruiting |
| Up0122 502 | Barcelona, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06888193